# VGLSD (VG Life Sciences Inc.) - SEC EDGAR Financial Statements

> VG Life Sciences Inc. reported $0 in revenue and a net loss of $4.30M for the trailing twelve months ended September 30, 2015.

- Canonical: https://convexityos.com/fundamentals/VGLSD
- Markdown: https://convexityos.com/fundamentals/VGLSD.md
- SEC CIK: 0001091326
- Reporting currency: USD
- Latest filing period: September 30, 2015
- Last synced: Nov 21, 2026, 05:03 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001091326&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Sep 30, 2015 |
| Operating Income | TTM | -$2.73M | Operating profit |
| Net Income | TTM | -$4.30M | GAAP bottom line |
| Diluted EPS | TTM | -$0.05 | Split-adjusted |
| Free Cash Flow | TTM | -$1.91M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2015 | $23K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2014 | FY 2013 |
| --- | --- | --- |
| **Revenue** | $0 | $0 |
| Research & Development | $866K | $809K |
| **Operating Income** | -$4.14M | -$3.91M |
| **EBITDA** | -$4.14M | -$3.91M |
| Interest Expense | $2.76M | $1.08M |
| Income Tax Expense | $0 | $0 |
| **Net Income** | -$6.19M | -$7.42M |
| Basic EPS | -$0.22 | -$0.91 |
| **Diluted EPS** | -$0.22 | -$0.91 |
| Basic Shares Outstanding | 27.6M | 8.2M |
| Diluted Shares Outstanding | 27.6M | 8.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 | Jun 2014 | Mar 2014 | Sep 2013 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $140K | $163K | $160K | -$110K | $340K | $224K | $412K | $300K |
| **Operating Income** | -$644K | -$739K | -$801K | -$541K | -$799K | -$1.15M | -$1.65M | -$854K |
| **EBITDA** | -- | -- | -- | -- | -$799K | -- | -- | -$854K |
| Interest Expense | $250K | $432K | $715K | $666K | $688K | $554K | $852K | $72K |
| **Net Income** | -$1.01M | -$1.40M | -$1.46M | -$424K | -$1.06M | -$2.00M | -$2.70M | -$1.55M |
| Basic EPS | -$0.01 | -$0.02 | -$0.03 | -- | -$0.04 | -$0.09 | -$0.14 | -$0.18 |
| **Diluted EPS** | -$0.01 | -$0.02 | -$0.03 | -- | -$0.04 | -$0.09 | -$0.14 | -$0.18 |
| Basic Shares Outstanding | 85.5M | 66.9M | 51.6M | -- | 28.9M | 22.8M | 18.9M | 8.4M |
| Diluted Shares Outstanding | 85.5M | 66.9M | 51.6M | -- | 28.9M | 22.8M | 18.9M | 8.4M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2014 | FY 2013 |
| --- | --- | --- |
| Cash & Cash Equivalents | $34K | $714K |
| **Cash & Short-Term Investments** | $34K | $714K |
| **Total Current Assets** | $246K | $789K |
| Property, Plant & Equipment, Net | $0 | $0 |
| Intangible Assets | $1.08M | $1.08M |
| **Total Non-Current Assets** | $1.08M | $1.08M |
| **Total Assets** | $1.32M | $1.87M |
| Accounts Payable | $710K | $405K |
| **Total Current Liabilities** | $5.83M | $6.33M |
| **Total Non-Current Liabilities** | $0 | $0 |
| **Total Liabilities** | $5.83M | $6.33M |
| Common Stock | $4.6K | $1.7K |
| Retained Earnings | -$106.0M | -$99.78M |
| **Total Stockholders' Equity** | -$4.51M | -$4.47M |
| Total Equity | -$4.51M | -$4.47M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 | Dec 2013 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $23K | $4.3K | $30K | $34K | $54K | $714K |
| **Cash & Short-Term Investments** | $23K | $4.3K | $30K | $34K | $54K | $714K |
| **Total Current Assets** | $40K | $39K | $92K | $246K | $60K | $789K |
| Property, Plant & Equipment, Net | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $1.08M | $1.08M | $1.08M | $1.08M | $1.08M | $1.08M |
| **Total Non-Current Assets** | $1.08M | $1.08M | $1.08M | $1.08M | $1.08M | $1.08M |
| **Total Assets** | $1.12M | $1.12M | $1.17M | $1.32M | $1.14M | $1.87M |
| Accounts Payable | $837K | $726K | $685K | $710K | $866K | $405K |
| **Total Current Liabilities** | $5.46M | $5.96M | $5.89M | $5.83M | $6.31M | $6.33M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $5.46M | $5.96M | $5.89M | $5.83M | $6.31M | $6.33M |
| Common Stock | $10K | $7.7K | $6.1K | $4.6K | $3.1K | $1.7K |
| Retained Earnings | -$109.8M | -$108.8M | -$107.4M | -$106.0M | -$105.5M | -$99.78M |
| **Total Stockholders' Equity** | -$4.34M | -$4.84M | -$4.73M | -$4.51M | -$5.17M | -$4.47M |
| Total Equity | -$4.34M | -$4.84M | -$4.73M | -$4.51M | -$5.17M | -$4.47M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2014 | FY 2013 |
| --- | --- | --- |
| Net Income | -$6.22M | -$7.48M |
| Depreciation & Amortization | $0 | $0 |
| Stock-Based Compensation | $0 | $0 |
| Change in Payables | $317K | $75K |
| **Operating Cash Flow** | -$1.91M | -$1.04M |
| Capital Expenditure | $0 | $0 |
| **Free Cash Flow** | -$1.91M | -$1.04M |
| **Investing Cash Flow** | $0 | $0 |
| Common Stock Issued | $0 | $0 |
| **Financing Cash Flow** | $1.23M | $1.75M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 | Jun 2014 | Mar 2014 | Sep 2013 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.02M | -$1.41M | -$1.47M | -$433K | -$1.07M | -$2.01M | -$2.71M | -$1.56M |
| Depreciation & Amortization | -- | -- | -- | -- | $0 | -- | -- | $0 |
| Stock-Based Compensation | $63K | $86K | $92K | -- | -- | -- | -- | -- |
| Change in Payables | $115K | $41K | $12 | -$145K | $2.8K | $202K | $256K | -- |
| **Operating Cash Flow** | -$48K | -$238K | -$165K | -$407K | -$468K | -$309K | -$725K | -- |
| **Financing Cash Flow** | $67K | $212K | $161K | $388K | $489K | $193K | $160K | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2014 | FY 2013 |
| --- | --- | --- |
| Return on Assets (ROA) | -467.8% | -397.6% |
| Current Ratio | 0.04x | 0.12x |
| Quick Ratio | 0.01x | 0.11x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 | Jun 2014 | Mar 2014 | Sep 2013 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -384.8% | -389.6% | -423.3% | -467.8% | -- | -- | -- | -- |
| Current Ratio | 0.01x | 0.01x | 0.02x | 0.04x | 0.01x | -- | -- | -- |
| Quick Ratio | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
